These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 1383923)
1. Competitive binding of a monoclonal antibody SZ-21 with anti-PLA1 antibodies and its potential for clinical application. Xi X; Zhao Y; Jiang H; Wu Q; Li P; Ruan C Nouv Rev Fr Hematol (1978); 1992; 34(3):239-42. PubMed ID: 1383923 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of binding of anti-PLA1 antibodies to platelets with monoclonal antibody LK-4. Evidence for multiple PLA1 receptor sites on platelet GPIIIa. Liu LX; Nardi MA; Casella JF; Karpatkin S Blood; 1996 Nov; 88(9):3601-7. PubMed ID: 8896429 [TBL] [Abstract][Full Text] [Related]
3. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody (LK-4) which differentiates PLA1 from PLA2 platelet extracts but not intact platelets. Liu LX; Nardi MA; Flug F; Karpatkin S Thromb Res; 1992 May; 66(4):309-20. PubMed ID: 1384161 [TBL] [Abstract][Full Text] [Related]
5. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets. Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345 [TBL] [Abstract][Full Text] [Related]
6. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response. Valentin N; Visentin GP; Newman PJ Blood; 1995 Jun; 85(11):3028-33. PubMed ID: 7756638 [TBL] [Abstract][Full Text] [Related]
7. A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope. Flug F; Espinola R; Liu LX; SinQuee C; DaRosso R; Nardi M; Karpatkin S Blood; 1991 May; 77(9):1964-9. PubMed ID: 1708295 [TBL] [Abstract][Full Text] [Related]
8. Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes. Liu LX; Nardi M; Flug F; Karpatkin S Br J Haematol; 1992 May; 81(1):113-7. PubMed ID: 1520609 [TBL] [Abstract][Full Text] [Related]
9. [Construction and characterization of bispecific single-chain antibody fragments SZ-2/SZ-21 against platelet glycoprotein Ib alpha and beta3]. Dai K; An G; Ruan C Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1493-7. PubMed ID: 12509914 [TBL] [Abstract][Full Text] [Related]
10. Localization of a PlA1 epitope to the amino terminal 66 residues of platelet glycoprotein IIIa. Bowditch RD; Tani PH; Halloran CE; Frelinger AL; McMillan R; Ginsberg MH Blood; 1992 Feb; 79(3):559-62. PubMed ID: 1370635 [TBL] [Abstract][Full Text] [Related]
11. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies. Kosugi S; Tomiyama Y; Shiraga M; Kashiwagi H; Mizutani H; Kanakura Y; Kurata Y; Matsuzawa Y Thromb Haemost; 1996 Feb; 75(2):339-45. PubMed ID: 8815587 [TBL] [Abstract][Full Text] [Related]
12. A structural/functional domain on human CD36 is involved in the binding of anti-Nak(a) antibodies. Daviet L; Morel-Kopp MC; Kaplan C; McGregor JL Thromb Haemost; 1995 Mar; 73(3):543-5. PubMed ID: 7545324 [TBL] [Abstract][Full Text] [Related]
13. A platelet monoclonal antibody inhibition assay for detection of glycoprotein IIb/IIIa-related platelet alloantibodies. Reiner AP; Teramura G; Nelson KA; Slichter SJ J Immunol Methods; 1995 Aug; 184(2):153-62. PubMed ID: 7658019 [TBL] [Abstract][Full Text] [Related]
14. Expression and purification of functional recombinant epitopes for the platelet antigens, PlA1 and PlA2. Barron-Casella EA; Kickler TS; Rogers OC; Casella JF Blood; 1994 Aug; 84(4):1157-63. PubMed ID: 7519475 [TBL] [Abstract][Full Text] [Related]
15. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. Furihata K; Nugent DJ; Bissonette A; Aster RH; Kunicki TJ J Clin Invest; 1987 Dec; 80(6):1624-30. PubMed ID: 2445781 [TBL] [Abstract][Full Text] [Related]
16. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency. Kutok JL; Coller BS Thromb Haemost; 1994 Dec; 72(6):964-72. PubMed ID: 7537915 [TBL] [Abstract][Full Text] [Related]
17. Characterization of an antibody to the integrin beta 3 subunit (GP IIIa) from a patient with neonatal thrombocytopenia and an inherited deficiency of GP IIb-IIIa complexes in platelets (Glanzmann's thrombasthenia). Jallu V; Pico M; Chevaleyre J; Vézon G; Kunicki TJ; Nurden AT Hum Antibodies Hybridomas; 1992 Apr; 3(2):93-106. PubMed ID: 1633270 [TBL] [Abstract][Full Text] [Related]
18. Antibody binding to platelet antigens in acute and chronic idiopathic thrombocytopenic purpura: a platelet membrane ELISA for the detection of antiplatelet antibodies in serum. Winiarski J; Ekelund E Clin Exp Immunol; 1986 Feb; 63(2):459-65. PubMed ID: 3698340 [TBL] [Abstract][Full Text] [Related]
19. A novel mechanism for exposure of fibrinogen binding sites on GPIIb-IIIa by a monoclonal antibody. Hato T; Watanabe A; Nakatani S; Minamoto Y; Fujita S Thromb Haemost; 1995 Jan; 73(1):138-43. PubMed ID: 7537917 [TBL] [Abstract][Full Text] [Related]
20. GPIIIa-related PLA1 antigens with different molecular weights: studies in platelets, endothelial cells, and megakaryocytes. Dancis A; Ehmann C; Ferziger R; Grima K; Karpatkin S Blood; 1988 Apr; 71(4):1056-61. PubMed ID: 3355887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]